KLDO Share Price | Kaleido Biosciences, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

150

Shareholding (Dec 2021)

FII

3.13%

Held by 20 FIIs

DII

28.74%

Held by 20 DIIs

Promoter

51.44%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.58

Return on Equity

-999,999.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Dec 2021)

Net Profit:

-20 Million

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

28.06%

EBIT Growth (5y)

-26.24%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

82.78%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.00

EV to EBIT

0.19

EV to EBITDA

0.20

EV to Capital Employed

2.72

EV to Sales

-15.20

PEG Ratio

Dividend Yield

ROCE (Latest)

1420.17%

ROE (Latest)

-851.21%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bullish

Bollinger Bands

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2021

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 24 Schemes (16.7%)

Foreign Institutions

Held by 20 Foreign Institutions (3.13%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'21 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2021 is 400.00% vs -50.00% in Sep 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2021 is 12.12% vs 3.35% in Sep 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'21",
        "Sep'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.50",
          "val2": "0.10",
          "chgp": "400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-19.10",
          "val2": "-21.80",
          "chgp": "12.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-20.30",
          "val2": "-23.10",
          "chgp": "12.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-40,038.60%",
          "val2": "-215,509.60%",
          "chgp": "17,547.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'21",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2021 is 10.00% vs 0.00% in Dec 2020",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2021 is -10.66% vs 5.45% in Dec 2020",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'21",
        "Dec'20",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.10",
          "val2": "1.00",
          "chgp": "10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-85.30",
          "val2": "-77.10",
          "chgp": "-10.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.80",
          "val2": "2.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-90.30",
          "val2": "-81.60",
          "chgp": "-10.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-79,408.50%",
          "val2": "-80,896.40%",
          "chgp": "148.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]